ImmuCell Corp (NASDAQ:ICCC)

Data as of 10:45am ET
 +0.0708 / +1.48%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

ImmuCell Corp. is a biotechnology company, which develops, manufactures and sells products to improve animal health and productivity in the dairy and beef industry. Its products focuses on encompasses prevention, diagnosis and treatment of economically important bovine diseases. ImmuCell was founded by Frank E. Ruch in 1982 and is headquartered in Portland, ME.

Contact Information

ImmuCell Corp.
56 Evergreen Drive
Portland Maine 04103
P:(207) 878-2770
Investor Relations:



Other institutional5.85%
Individual stakeholders29.98%
Mutual fund holders2.64%

Top Executives

Michael F. BrighamPresident, CEO, CFO, Secretary & Treasurer
Joseph H. CrabbDirector, Chief Scientific Officer & VP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.